Lenskart IPO: Lenskart Solutions Rs 7,278 crore IPO closed on November 4 with strong demand, being subscribed 28.2 times after receiving bids for 281.9 crore shares against 9.97 crore on offer. The basis of allotment will be finalized on November 6, and investors can check their allotment status on the BSE or MUFG Intime India websites.
The National Stock Exchange (NSE) has set aside Rs 1,300 crore to settle pending Sebi cases, signalling progress toward its long-awaited IPO. The move clears a major regulatory hurdle, even as Q2 profits declined due to lower trading volumes and a one-time settlement provision.
ETMutualFunds.com has shortlisted the best large & mid cap funds for November 2025 based on rolling returns, consistency measured through the Hurst Exponent, downside risk, Jensens Alpha, and minimum asset size. The recommended list includes schemes from Axis, Mirae Asset, Canara Robeco, Sundaram, Kotak and Quant. These funds balance growth and stability but require investors to tolerate moderately higher risk.
LIC is set to announce its September quarter results on Thursday, with brokerages expecting up to a 10% year-on-year drop in its Annual Premium Equivalent (APE) to Rs 14,84016,380 crore. Estimates for Value of New Business (VNB) range between Rs 2,374 crore and Rs 3,018 crore.
Ace investor Mukul Mahavir Agrawal reshuffled his portfolio in Q2FY26, adding 10 new stocks worth Rs 400 crore across sectors like consumer durables, healthcare, technology, and renewables. The diversification highlights his confidence in Indias growth themes, with notable investments in IFB Industries, Osel Devices, Coforge, and Zelio E-Mobility.
Indias IT services sector showed stabilisation in Q2, with improved execution, resilient margins, and supportive currency effects. AI adoption is shifting from trials to implementation, opening medium-term opportunities. Stocks like HCL Technologies and Coforge offer healthy growth visibility and valuation comfort.
Abolishing GST on health and life insurance has immediately reduced premiums by 18%, making financial protection more accessible for millions, especially the 'missing middle'. This reform, coupled with reduced GST on medical devices and medicines, aims to lower treatment costs and make quality healthcare truly inclusive and affordable for all Indians.
Groww has surpassed Zerodha in active user count, capturing a significant market share by targeting first-time investors and underserved cities. Despite this user base advantage, Zerodha maintains a lead in profitability and revenue per user. Both platforms face headwinds from regulatory scrutiny on derivatives trading and increased competition.
